Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
Security class unavailable · CUSIP: 89422G107
Event date: 2021-08-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-21-001685
- Form type
- SC 13G
- Filer
- Deep Track Capital, LP
- CIK
- CIK 1856083
- Filed
- Aug 13, 2021
- Reporting period
- Aug 04, 2021
- Description
- Schedule 13G beneficial ownership